Bollinger, A.; Semedo Fortes, M.; Meyer zu Schwabedissen, H.E.; Hersberger, K.E.; Stäuble, C.K.; Allemann, S.S.
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective. Pharmacy 2025, 13, 14.
https://doi.org/10.3390/pharmacy13010014
AMA Style
Bollinger A, Semedo Fortes M, Meyer zu Schwabedissen HE, Hersberger KE, Stäuble CK, Allemann SS.
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective. Pharmacy. 2025; 13(1):14.
https://doi.org/10.3390/pharmacy13010014
Chicago/Turabian Style
Bollinger, Anna, Melissa Semedo Fortes, Henriette E. Meyer zu Schwabedissen, Kurt E. Hersberger, Céline K. Stäuble, and Samuel S. Allemann.
2025. "Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective" Pharmacy 13, no. 1: 14.
https://doi.org/10.3390/pharmacy13010014
APA Style
Bollinger, A., Semedo Fortes, M., Meyer zu Schwabedissen, H. E., Hersberger, K. E., Stäuble, C. K., & Allemann, S. S.
(2025). Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective. Pharmacy, 13(1), 14.
https://doi.org/10.3390/pharmacy13010014
